Skip to main content
Log in

Validation of an in vitro screen for phospholipidosis using a high-content biology platform

  • Published:
Cell Biology and Toxicology Aims and scope Submit manuscript

Abstract

Several cationic amphiphilic drugs cause local or systemic phospholipidosis (PLD) after chronic exposure in preclinical species. PLD is characterized by the accumulation of drug, phospholipid, and concentric lamellar bodies in cellular lysosomes. We have developed a fluorescence-based in vitro screen that is predictive of PLD using the Cellomics ArrayScan high-content screening platform, which captures and analyzes images from 96-well cell culture microtiter plates using multichannel fluorescence microscopy. I-13.35 adherent mouse spleen macrophage cells were cultured with drug and a fluorescently tagged phospholipid, N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine (NBD-PE). Drug concentrations were used in a range from 1 to $100 μmol/L. After 24 h incubations, the cells were fixed with formalin. NBD-PE uptake was quantified in controls and treated cells. Nuclei were identified by Hoechst 33258 staining and dead cells were identified using ethidium homodimer-2 incorporation. Thus, confounding accumulation of NBD-PE due to cytotoxicity that produces false-positive results at high concentrations was eliminated from quantitation by ethidium staining and employing cell gating (dead cell rejection). The assay was found to be both sensitive and selective in that 26 of 28 positive, phospholipidogenic controls and 8 of 8 negative, nonphospholipidogenic controls were correctly called.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Abbreviations

CADs:

cationic amphiphilic drugs

DMSO:

dimethyl sulfoxide

EthD-2e:

ethidium homodimer-2 dead cell stain

HCB:

high-content biology

NBD-PE:

N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)-1,2-hexadecanoyl-sn-glycero-3-phosphoethanolamine triethylammonium salt

PLD:

phospholipidosis

References

  • Bockhardt H, Lullmann-Rauch R. Zimelidine-induced lipidosis in rates. Acta Pharmacol Toxicol (Copenh). 1980;47(1):45–8.

    CAS  Google Scholar 

  • Casartelli A, Bonato M, Cristofori P, et al. A cell-based approach for the early assessment of the phospholipidogenic potential in pharmaceutical research and drug development. Cell Biol Toxicol. 2003;19:161–76.

    Article  CAS  PubMed  Google Scholar 

  • Cox JW, Ulrich RG, Wynalda MA, et al. Reversible, hepatic, lysosomal phospholipidosis in rat induced by subchronic daily administration of trospectomycin sulfate. Biochem Pharmacol. 1989;38(20): 3535–41.

    Google Scholar 

  • Cramer CT, Ulrich RC. Cytotoxicity and lamellar body induction potential of a racemic benzamide antiarrhythmic compound and enantiomers in cultured rat hepatcotyes. Toxicol In Vitro. 1994;5:1083–90.

    Google Scholar 

  • Dake MD, Madison JM, Montgomery CK, et al. Electron microscopic demonstration of lysosomal inclusion bodies in lung, liver, lymph nodes, and blood leukocytes of patients with amiodarone pulmonary toxicity. Am J Med. 1985;78:506–12.

    Article  CAS  PubMed  Google Scholar 

  • Drenckhahn D, Kleine L, Lullmann-Rauch R. Lysosomal alterations in cultured macrophages exposed to anorexigenic and psychotropic drugs. Lab Invest. 1976;35(2):116–23.

    CAS  PubMed  Google Scholar 

  • Drew R, Siddik ZH, Mimnaugh EG, Gram TE. Species and dose differences in the accumulation of imipramine by mammalian lungs. Drug Metab Dispos. 1981;9:322–6.

    CAS  PubMed  Google Scholar 

  • Frisch W, Lullmann-Rauch R. Differential effects of chloroquine and of several other amphiphilic cationic drugs upon rat choroid plexus. Acta Neuropathol (Berl). 1979;46(3):203–8.

    CAS  Google Scholar 

  • Gonzalez-Rothi RJ, Zander DS, Ros PR. Fluoxetine hydrochloride (Prozac) induced pulmonary disease. Chest. 1995;107:1763–5.

    CAS  PubMed  Google Scholar 

  • Gum R, Hickman D, Fagerland JA, et al. Analysis of two matrix metalloproteinase inhibitors and their metabolites for induction of phospholipidosis in rat and human hepatocytes. Biochem Pharmacol. 2001;62:1661–73.

    Article  CAS  PubMed  Google Scholar 

  • Halliwell WH. Cationic amphiphilic drug-induced phospholipidosis. Toxicol Pathol. 1997;25:53–60.

    CAS  PubMed  Google Scholar 

  • Hollemans M, Elferink RO, DeGroot PG, Strijland A, Tager JM. Accumulation of weak bases in relation to intralysosomal pH in cultured human skin fibroblasts. Biochim Biophys Acta. 1981;643:140–51.

    CAS  PubMed  Google Scholar 

  • Honegger UE, Roscher AA, Wiesmann UN. Evidence for lysosomotropic action of desipramine in cultured human fibroblasts. J Pharmacol Exp Ther. 1983;225(2):436–41.

    CAS  PubMed  Google Scholar 

  • Horn JW, Jensen CB, White SL, et al. In vitro and in vivo ultrastructural changes induced by macrolide antibiotic LY281389. Fundam Appl Toxicol. 1996;32:205–16.

    Article  CAS  PubMed  Google Scholar 

  • Hostetler KY, Richman DD. Studies on the mechanism of phospholipid storage induced by amantadine and chloroquine in Madin Darby canine kidney cells. Biochem Pharmacol. 1982;31(23):3795–9.

    Article  CAS  PubMed  Google Scholar 

  • Hostetler KY, Reasort M, Yazaki PJ. Chloroquine-induced phospholipid fatty liver: measurements of drug and lipid concentrations in rat liver lysosomes. J Biol Chem. 1985;260:215–9.

    CAS  PubMed  Google Scholar 

  • Hostetler KY, Giordano JR, Jellison EJ. In vitro inhibition of lysosomal phospholipase A of rat lung by amiodarone and desethylamiodarone. Biochim Biophys Acta. 1988;959:316–21.

    CAS  PubMed  Google Scholar 

  • Joshi UM, Rao P, Kodacanit S, Coudert B, Dwyer TM, Mehendale HM. Types of interaction of amphiphilic drugs with phospholipid vesicles. J Pharmacol Exp Ther. 1988;246:150–7.

    CAS  PubMed  Google Scholar 

  • Joshi UM, Kodavanti PRS, Lockard VG, Mehendale HM. Fluorescence studies on binding of amphiphilic drugs to isolated lamellar bodies: relevance to phospholipidosis. Biochim Biophys Acta. 1989;1004:309–20.

    CAS  PubMed  Google Scholar 

  • Jung HJ, Suzuki Morphological changes in CNS of rats treated with perhexiline maleate (pexid). Acta Neuropathol (Berl). 1978;42(3):159–64.

    CAS  Google Scholar 

  • Kacew S, Reasor MJ. Newborn response to cationic amphiphilic drugs. Federation Proceedings. 1985;44(7):2323–7.

    Google Scholar 

  • Kacew S. Cationic amphiphilic drug-induced renal cortical lysosomal phospholipidosis: an in vivo comparative study with gentamicin and chlorphentermine. Toxicol Appl Pharmacol. 1987;91(3):469–76.

    Article  CAS  PubMed  Google Scholar 

  • Kannan R, Sarma J, Guha M, Venkataraman K. Amiodarone toxicity: II. Desethylamiodarone-induced phospholipidosis and ultrastructural changes during repeated administration in rats. Fundam Appl. Toxicol. 1991;16(1):103–9.

    Article  CAS  PubMed  Google Scholar 

  • Kodavanti UP, Mehendale HM. Cationic amphiphilic drugs and phospholipid storage disorder. Pharm Rev. 1990;42:327–53.

    CAS  PubMed  Google Scholar 

  • Kodavanti UP, Lockard VG, Mehendale HM. In vivo toxicity and pulmonary effects of promazine and chlorpromazine in rats. J Biochem Toxicol. 1990;5:245–54.

    CAS  PubMed  Google Scholar 

  • Lullmann H, Lullmann-Rauch R. Tamoxifen-induced generalized lipidosis in rats subchronically treated with high doses. Toxicol Appl Pharmacol. 1981;61(1):138–46.

    Article  CAS  PubMed  Google Scholar 

  • Lullman-Rauch R, Nassberger L. Citalopram-induced generalized lipidosis in rats. Acta Pharmacol Toxicol. 1983;52(3):161–7.

    Google Scholar 

  • Lullmann-Rauch R. Tilorone-induced lysosomal storage mimicking the features of mucopolysaccharidosis and of lipidosis in rat liver. Virchows Archiv B Cell Pathol. 1983;44(3):355–68.

    CAS  Google Scholar 

  • Matsuzawa Y, Hostetler KY. Studies on drug induced lipidosis: subcellular localization of phopholipid and cholesterol in the liver of rats treated with chloroquine or 4,4-bis(diethylaminoethoxy) a,b-diethyldiphenylethane. J Lipid Res. 1980;21:202–14.

    CAS  PubMed  Google Scholar 

  • McCloud M, Beard T, Kacew S, Reasor M. In vivo and in vitro reversibility of chlorphentermine-induced phospholipidosis in rat alveolar macrophages. Exp Mol Pathol. 1995;62:12–21.

    Article  CAS  PubMed  Google Scholar 

  • Reasor MJ. A review of the biology and toxicologic implications of the induction of lysosmol lamellar bodies by drugs. Toxicol Appl Pharmacol. 1989;97:47–56.

    CAS  PubMed  Google Scholar 

  • Reasor MJ, Kacew S. Drug-induced phospholipidosis: are there functional consequences? Exp Biol Med. 2001;226:825–30.

    CAS  Google Scholar 

  • Sauers LJ, Wierda D, Walker ER, Reasor MJ. Morphological and functional changes in mouse splenic lymphocytes following in vivo and in vitro exposure to chlorphentermine. J Immunopharmacol. 1986;8(4):611–31.

    CAS  PubMed  Google Scholar 

  • Sawada H, Takami K, Asahi S. A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system. Toxicol Sci. 2005;83(2):282–92.

    CAS  PubMed  Google Scholar 

  • Shaikh NA, Downar E, Butany J. Amiodarone – an inhibitor of phospholipase activity: a comparative study of the inhibitory effect of amiodarone, chloroquine and chlorpromazine. Mol Cell Biochem 1987;76:163–72.

    Article  CAS  PubMed  Google Scholar 

  • Tanaka H, Furusato M, Takasaki S, Watanabe M, Hattori Y. Morphological and biochemical alteration in the rat liver induced by maprotiline. Acta Pathol Jpn. 1975;25(4):413–37.

    CAS  PubMed  Google Scholar 

  • Ulrich RG, Kilgore KS, Sun EL, Cramer CT, Ginsburg LC. An in vitro fluorescence assay for the detection of drug-induced cytoplasmic lamellar bodies. Toxicol Methods. 1991;1(2):89–105.

    CAS  Google Scholar 

  • Van Bambeke F, Montenez JP, Piret J, Tulkens PM, Courtoy PJ, Mingeot-Leclercq MP. Interaction of the macrolide azithromycin with phospholipids. I. Inhibition of lysosomal phospholipase A1 activity. Eur J Pharmacol. 1996;314(1–2):203–14.

    CAS  PubMed  Google Scholar 

  • Westphal JF, Vetter D, Brogard JM. Hepatic side effects of antibiotics. J Antimicrob Chemother. 1994:33(3):387–401.

    CAS  PubMed  Google Scholar 

  • Whitehouse LW, Menzies A, Mueller R, Pontefract R. Ketoconazole-induced hepatic phospholipidosis in the mouse and its association with de-N-acetyl ketoconazole. Toxicology. 1994;94(1–3):81–95.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to J. K. Morelli.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morelli, J.K., Buehrle, M., Pognan, F. et al. Validation of an in vitro screen for phospholipidosis using a high-content biology platform. Cell Biol Toxicol 22, 15–27 (2006). https://doi.org/10.1007/s10565-006-0176-z

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10565-006-0176-z

Keywords

Navigation